Hasil Pencarian - Brunner H

  • Menampilkan 1 - 5 hasil dari 5
Perbaiki Hasil
  1. 1
    Crystal structure of η6 -benzene(chloro)(N-[(5)-(-)1-phenylethyl]-thiobenzamidato)ruthenium(II), (C6H6)Ru(C15H14NS)Cl

    Crystal structure of η6 -benzene(chloro)(N-[(5)-(-)1-phenylethyl]-thiobenzamidato)ruthenium(II), (C6H6)Ru(C15H14NS)Cl oleh Brunner H., Zwack Th., Zabel M.

    Diterbitkan 2002-12-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  2. 2
    Crystal structure of bis(2-N,N-dimethylamino-6-methylpyridine-5-yl)- methane, C17H24N4

    Crystal structure of bis(2-N,N-dimethylamino-6-methylpyridine-5-yl)- methane, C17H24N4 oleh Brunner H., Köllnberger Α., Zabel M.

    Diterbitkan 2003-12-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  3. 3
    Crystal structure of η6 -benzene(chloro)(N-[(5)-(-)1-phenylethyl]-thiobenzamidato)ruthenium(II), (C6H6)Ru(C15H14NS)Cl

    Crystal structure of η6 -benzene(chloro)(N-[(5)-(-)1-phenylethyl]-thiobenzamidato)ruthenium(II), (C6H6)Ru(C15H14NS)Cl oleh Brunner H., Zwack Th., Zabel M.

    Diterbitkan 2002-12-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  4. 4
    Efficacy and safety of canakinumab, a long acting fully human anti-Interleukin-1β antibody, in systemic juvenile idiopathic arthritis with active systemic features: results from a phase III study

    Efficacy and safety of canakinumab, a long acting fully human anti-Interleukin-1β antibody, in systemic juvenile idiopathic arthritis with active systemic features: results from a... oleh McCann L, Ozdogan H, Rutkowska-Sak L, Ferrandiz MA, Wulffraat NM, Brik R, Kallinich T, Erguven M, Berkun Y, Constantin T, Quartier P, Horneff G, Brunner H, Ruperto N, Lheritier K, Preiss R, Tseng L, Martini A, Lovell DJ

    Diterbitkan 2011-09-01
    Artikel
    Simpan ke Daftar
    Disimpan di:
  5. 5
    Efficacy and safety of tocilizumab (TCZ) in patients with systemic juvenile idiopathic arthritis (SJIA): tender 52-week data

    Efficacy and safety of tocilizumab (TCZ) in patients with systemic juvenile idiopathic arthritis (SJIA): tender 52-week data oleh Espada G, Pardeo M, Chaitow J, Brown D, Allen R, Zulian F, Zuber Z, Wulffraat N, Joos R, Dolezalova P, Burgos-Vargas R, Woo P, Schneider R, Ruperto N, Brunner H, De Benedetti F, Flato B, Gerloni V, Horneff G, Wright S, Kenwright A, Lovell D, Martini A

    Diterbitkan 2011-09-01
    Artikel
    Simpan ke Daftar
    Disimpan di:

Alat Pencarian: